LQPE yields 0.28% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, LQPE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LQPE + JNJ for your $10,000?
LQPE seeks to outperform the public equity markets by replicating traditional private equity (PE) funds focused on leveraged buyouts. The actively managed portfolio comprises 70-80% equity securities and 20-30% derivatives. The funds equity component consists of US-listed stocks of any market size that mirror the industries and company characteristics typically targeted by PE funds. Securities are selected based on the sub-advisers analysis of PE data and its proprietary models. The funds dividend component includes futures contracts and futures-related instruments designed to increase equity exposure and reduce downside volatility relative to public equity markets. LQPE gains exposure to futures contracts and other derivative instruments either directly or indirectly by investing up to 25% of its assets in a wholly owned Cayman Islands subsidiary. Lastly, the fund invests in cash, short-term US Treasury securities, money market funds, and cash equivalents to serve as collateral.
Full LQPE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.